Work Here?
Industries
Healthcare
Company Size
51-200
Company Stage
Grant
Total Funding
$284.5M
Headquarters
San Jose, California
Founded
2012
Visby Medical specializes in rapid PCR tests for detecting infectious diseases, providing results in under 30 minutes. This is a major improvement over traditional PCR tests that can take days for results. Their clients are mainly healthcare providers in the U.S., and they produce portable PCR testing kits suitable for clinical and mobile lab use. What sets Visby apart is their compact, instrument-free design, allowing a PCR lab's functionality to fit in the palm of your hand. The goal of Visby Medical is to deliver accurate and quick results to enhance patient diagnosis and treatment, reducing the common issues of patient callbacks and follow-ups in healthcare. Their revenue comes from selling these testing kits, which are increasingly important in today's health landscape.
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$284.5M
Above
Industry Average
Funded Over
6 Rounds
Health Insurance
Health Savings Account/Flexible Spending Account
401(k) Company Match
Unlimited Paid Time Off
Paid Holidays
Last month, Visby also acquired a 510(k) clearance from the FDA for its point-of-care respiratory disease test, designed to catch influenza A and B as well as the coronavirus behind COVID-19.
Visby Medical has secured an additional $3.9 million from CARB-X to enhance its PCR-based diagnostics for antibiotic resistance, building on a previous $1.2 million grant. The funding will aid in developing tools to detect resistance mutations in infections, starting with ciprofloxacin susceptibility in Neisseria gonorrhoeae. Visby aims to integrate these capabilities into its Sexual Health Test and develop a digital app for result interpretation.
SAN JOSE, Calif., Jan. 15, 2025 /PRNewswire/ - Visby Medical(TM), a leading innovator in rapid PCR diagnostics, has secured an additional $3.9 million from the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) to accelerate its fight against antibiotic resistance.
The portable, instrument-free PCR test will be used to detect infections resistant to the frontline antibiotic ciprofloxacin and help reduce use of ceftriaxone.
CARB-X awards $1.8 million to Visby Medical to develop a portable rapid PCR test for gonorrhea.
Find jobs on Simplify and start your career today
Discover companies similar to Visby Medical
Industries
Healthcare
Company Size
51-200
Company Stage
Grant
Total Funding
$284.5M
Headquarters
San Jose, California
Founded
2012
Find jobs on Simplify and start your career today
Discover companies similar to Visby Medical